Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer

Showing results (451-460 of 41,513) with videos related to

Pageof 4,152
Sort By:
Cancer|January 23, 1998
Diagnostic pitfalls of aspiration cytology of salivary duct carcinomaK K Khurana, M B Pitman, C N Powers, et al.
Cancer|February 6, 1998
Genomic aberrations in early stage human hepatocellular carcinomasH Nagai, M Ponglikitmongkol, J Fujimoto, et al.
Cancer|February 6, 1998
Pulmonary blastoma: case report of a patient with a 7-year remission and review of chemotherapy experience in the world literatureC S Cutler, R P Michel, M Yassa, et al.
Cancer|February 6, 1998
A French national epidemiologic survey on renal cell carcinoma. Oncology Committee of the Association Française d'UrologieD Bretheau, A Koutani, E Lechevallier, et al.
Cancer|February 6, 1998
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumorsC A Bunnell, L Thompson, L Buswell, et al.
Cancer|February 6, 1998
Mantle cell lymphoma: presenting features, response to therapy, and prognostic factorsF Bosch, A López-Guillermo, E Campo, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Cancer|January 28, 1998
Why is the prostate cancer death rate declining in the United States?C J Mettlin, G P Murphy
Cancer|January 28, 1998
T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinomaJ J Jian, S H Cheng, L R Prosnitz, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Pageof 4,152

Showing results (451-460 of 41,513) with videos related to

Sort By:
Pageof 4,152
Cancer|January 23, 1998
Diagnostic pitfalls of aspiration cytology of salivary duct carcinomaK K Khurana, M B Pitman, C N Powers, et al.
Cancer|February 6, 1998
Genomic aberrations in early stage human hepatocellular carcinomasH Nagai, M Ponglikitmongkol, J Fujimoto, et al.
Cancer|February 6, 1998
Pulmonary blastoma: case report of a patient with a 7-year remission and review of chemotherapy experience in the world literatureC S Cutler, R P Michel, M Yassa, et al.
Cancer|February 6, 1998
A French national epidemiologic survey on renal cell carcinoma. Oncology Committee of the Association Française d'UrologieD Bretheau, A Koutani, E Lechevallier, et al.
Cancer|February 6, 1998
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumorsC A Bunnell, L Thompson, L Buswell, et al.
Cancer|February 6, 1998
Mantle cell lymphoma: presenting features, response to therapy, and prognostic factorsF Bosch, A López-Guillermo, E Campo, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Cancer|January 28, 1998
Why is the prostate cancer death rate declining in the United States?C J Mettlin, G P Murphy
Cancer|January 28, 1998
T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinomaJ J Jian, S H Cheng, L R Prosnitz, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Pageof 4,152